A company that deals in the research, development & trading of health products is looking for suppliers of Various Finished Dosage Formulations for commercial purposes. The suppliers must support this enquiry with CTD Dossier.
1. Pembrolizumab (100 mg) Injections
2. Paclitaxel (6 mg, 30 mg, 100 mg, 150 mg & 300 mg) Injections
3. Nivolumab (40 mg & 100 mg) Injections
4. Oxaliplatin (5 mg, 50 mg & 100 mg) Injections
5. Bevacizumab (25 mg) Injections
28 Jan 2023